Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers
Rajat Thawani,
Matteo Repetto,
Clare Keddy,
Katelyn Nicholson,
Kristen Jones,
Kevin Nusser,
Catherine Z. Beach,
Guilherme Harada,
Alexander Drilon,
Monika A. Davare
Affiliations
Rajat Thawani
Section of Hematology/Oncology, Department of Medicine, University of Chicago
Matteo Repetto
Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College
Clare Keddy
Department of Pediatrics, Oregon Health & Science University
Katelyn Nicholson
Department of Pediatrics, Oregon Health & Science University
Kristen Jones
Department of Pediatrics, Oregon Health & Science University
Kevin Nusser
Department of Pediatrics, Oregon Health & Science University
Catherine Z. Beach
Department of Pediatrics, Oregon Health & Science University
Guilherme Harada
Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College
Alexander Drilon
Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College
Monika A. Davare
Department of Pediatrics, Oregon Health & Science University
